Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

First clinical trials results reported for leptin

June 18, 1997

Zonagen reports results of second phase III trial of Vasomax

June 17, 1997

New vial size of generic leucovorin approved by FDA

June 17, 1997

Vitamin E for maternal diabetes-associated malformations in offspring

June 16, 1997

Neurogen reports promising phase I results with antiobesity drug

June 13, 1997

Osiris and Activated Cell Therapy initiate MSC collaboration

June 13, 1997

Testosterone transdermal patch now available in the U.S. in a once-daily formulation

June 13, 1997

Combination insulin sensitizer + alpha-glucosidase inhibitor for diabetes

June 13, 1997

Fibrinogen antagonists in IDDM

June 13, 1997

Results of D1/D2 receptor coactivation in diabetes

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...